Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

Still, more than a quarter of employers are considering adding coverage for GLP-1 drugs for weight loss in 2025 or 2026, according to a national survey conducted this year by Mercer, a human resources ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

Achieving weight loss within a year of initiating orlistat can reduce the risk for both incident gout and recurrent gout ...

The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) ...

New-generation anti-obesity drug Wegovy, made by the same company that created Ozempic, is now available in France – but it ...

That’s according to a new Employer Health Benefits Survey from KFF (formerly the Kaiser Family Foundation). But while a ...

Three cities in Hawaii, Minnesota, and Texas report the highest usage of injectable weight loss medications. Meanwhile, ...

Hoping your company will begin paying for anti-obesity medications like Wegovy? You may be in luck. A growing number of employers are considering covering the blockbuster weight-loss drugs ...